# Delta-THC in Behavioral Disturbances in Dementia

> **NCT01302340** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 22 (actual)

## Conditions studied

- Dementia

## Interventions

- **DRUG:** Delta-THC
- **DRUG:** placebo
- **DRUG:** Delta-THC

## Key facts

- **NCT ID:** NCT01302340
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2014-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01302340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01302340, "Delta-THC in Behavioral Disturbances in Dementia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01302340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*